Table 1c.
Number of campaigns planned to take place from March 2020 to December 2021 that were postponed or canceled (fully or partially) because of COVID-19, as of May 15, 2021
| Diseases/ Vaccines | No. of countries with postponed or canceled campaigns | No. of postponed or canceled campaign/ Total no. of planned campaigns |
No. of campaigns postponed or canceled by regions |
|||||
|---|---|---|---|---|---|---|---|---|
| AFR | AMR | EMR | EUR | SEAR | WPR | |||
| Measles containing vaccines (MCV) | 23 | 23/78 (29%) | 4 | 6 | 2 | 6 | 3 | 2 |
| Polio vaccines | 30* | 40 /246 (16%) | 28 | 1 | 5 | 0 | 5 | 1 |
| a) Inactivated polio vaccine (IPV) | 13 | 13/26 (50%) | 10 | 0 | 0 | 0 | 2 | 1 |
| b) Bivalent oral polio vaccine types1&3 (bOPV)/Trivalent oral polio vaccine (tOPV) | 15 | 18/90 (20%) | 10 | 1 | 4 | 0 | 3 | 0 |
| c) Monovalent oral polio vaccine type2 (mOPV2)/ Novel oral polio vaccine type 2 (nOPV2) | 5 | 9/130 (7%) | 8 | 0 | 1 | 0 | 0 | 0 |
| Meningitis A (Men A) | 3 | 3/7 (43%) | 3 | 0 | 0 | 0 | 0 | 0 |
| Yellow fever (YF) | 2 | 2/21 (10%) | 1 | 0 | 1 | 0 | 0 | 0 |
| Typhoid (TCV) | 2 | 2/3 (67%) | 2 | 0 | 0 | 0 | 0 | 0 |
| Cholera (OCV) | 5 | 5/16 (31%) | 2 | 0 | 1 | 0 | 2 | 0 |
| Tetanus- diphtheria (Td) | 4 | 4/15 (27%) | 1 | 0 | 1 | 0 | 0 | 2 |
| Total | 53* | 79/386 (20%) | 41 | 7 | 10 | 6 | 10 | 5 |
* Total no. of countries with at least 1 VPD immunization campaign postponed (fully or partially)